Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Commercial

Set Alert for Commercial

Telehealth Sees Skyrocketing Demand Amid Regulatory Expansion, Hopes To Last Beyond COVID-19 Crisis

US telehealth companies are seeing skyrocketing demand for devices and services, which offers opportunities and challenges during this COVID-19 crisis.

Infectious Diseases Coronavirus COVID-19 Innovation

Companies

Set Alert for Companies

Latest From Companies

Smiths Medical Ramps Up ParaPAC Ventilator Production For UK Order Of 10,000 Units

Smiths Medical is increasing paraPAC ventilator production from hundreds to thousands a month to fulfill 10,000 units as part of the Ventilator Challenge UK consortium.

United Kingdom Coronavirus COVID-19

Battelle Decontamination System Gets EUA To Fight Respirator Shortage

The US FDA has issued an emergency use authorization for a Battelle decontamination system to clean N95 masks, which are currently facing a shortage due to the COVID-19 pandemic. The company says it can clean up to 80,000 respirator masks a day from participating health care providers.

Approvals Companies

Temporary Guidance Relaxes Oversight of Sterilizers, Disinfectant Devices, Air Purifiers

The US FDA published on 29 March an emergency temporary guidance that relaxes oversight of certain sterilizers, disinfectant devices and air purifiers intended to kill the SARS-CoV-2 virus.

Regulation Policy
See All

Deals and Financings

Set Alert for Deals

Latest From Deals

Thermo Fisher Scientific Announces $11.5Bn Buyout Of Qiagen

Thermo Fisher expects the deal to improve its portfolio of specialty diagnostics for clinical labs while its genetic analysis technologies, biosciences reagents and consumable products will complement Qiagens’ sample preparation and assay technologies.

M & A Deals

LSX 2020: Medtronic, J&J And Olympus Map Their M&A Outlook

At the LSX World Congress in London, leaders from Medtronic, Johnson & Johnson and Olympus discussed the evolving medtech mergers and acquisitions landscape, the big opportunity in robotic surgery and the impacts on innovation of the forthcoming EU Medical Device Regulation.

M & A Deals

Report: Securities Lawsuits Against Life Sciences Firms Still On The Rise

More investor suits were brought against life sciences companies in 2019 than in any of the past five years, according to a new report from law firm Dechert LLP. The increase continues a trend that has seen the number of such suits more than double since 2014.

Legal Issues Deals
See All

Market Access

Set Alert for Market Access

Latest From Market Access

England's NICE To Focus On COVID-19 And Other Critical Therapies

The health technology assessment institute is taking a virtual approach to meetings and has said that it can provide free fast-track advice for companies developing novel diagnostics or therapeutics for the coronavirus.

Health Technology Assessment Coronavirus COVID-19

QUOTED. 20 March 2020. Paul Chrisp.

England’s health technology assessment body has eased back on a draft recommendation against using endovascular aneurysm repair (EVAR) on unruptured abdominal aortic aneurysms. See what Paul Chrisp, director of the Centre for Guidelines at NICE, had to say about the new guidance.

Quoted United Kingdom

NICE Tempers Controversial Recommendation Against England Using Endovascular Aneurysm Repair

While it no longer unequivocally rules out EVAR, the health technology assessment body says it wants to see procedures shift toward open surgery, in line with the evidence.

United Kingdom Health Technology Assessment
See All

Market Intelligence

Set Alert for Market Intelligence

Latest From Market Intelligence

Market Intel: Medtech Giants Ready To Battle Frontrunner Intuitive Surgical In 'Soft Surgery Robotics'

The global market for robotic surgery systems is expected to reach $9.7bn by 2023. With medtech giants Medtronic, Johnson & Johnson and Zimmer Biomet launching robotic platforms in 2020, this market is set for a major shakeup.

Market Intelligence Robotic Surgery

QUOTED. 20 February 2020. Steven Raman.

Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.

Quoted Market Intelligence

Market Intel: Minimally Invasive Procedures Gaining Traction In BPH Treatment Market

Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Landmark studies of newer techniques have led the American Urological Association to update its guidelines.

Market Intelligence Cancer
See All

Appointments

Set Alert for Appointments

Latest From Appointments

Execs On The Move: New Global Comms Boss At Siemens; CRH CEO Now Also Chair; New CEO At ChroniSense Medical

German multinational firm Siemens picks a global communications head; CRH Medical CEO also takes on chairmanship; ChroniSense Medical, a developer of medical monitoring devices, hires a new CEO; and more.

Commercial Appointments

Execs On The Move: Industry Veterans With Proven Track Records Chosen To Lead At Chembio, Oxford BioDynamics And Ra Medical

A CEO is chosen at three companies: Chembio Diagnostic Systems, a producer of point-of-care infectious disease diagnostics; Oxford BioDynamics, a developer of epigenetic biomarkers; and Ra Medical Systems, a maker of excimer laser systems.

Appointments Commercial

Thermo Fisher Announces Plan To Pay For Qiagen; Bernard Confirmed As Qiagen CEO

Thermo Fisher has priced an offering of $2.2bn senior notes to pay for its planned acquisition of Qiagen. The news comes the same week, Qiagen confirmed Thierry Bernard as permanent CEO following the departure of former leader Peer Schatz. 

Appointments Financing
See All
UsernamePublicRestriction

Register